Shots:

• The acquisition will bolster Verily’s clinical trial system and Baseline platform to improve the efficiency- costs in clinical trials & speed up it at research sites globally. It also collects patient data for site-based- hybrid- and decentralized clinical studies
• SignalPath’s platform leverages modern software architecture with a cloud-based platform to reduces fragmentation & advance the management of clinical trials portfolio
• SignalPath employees will join Verily’s clinical research business to increase its geographic footmark in North Carolina while maintaining its physical presence in Raleigh

  | Ref: Businesswire | Image: Stat News